With a market capitalization (market cap) of $1.08B — a measure of how much the company is worth — Apnimed, Inc. is the 2534th most valuable company in Healthcare as of August 10, 2026. Shares trade at $27.00, down +3.16% on the day.
of 2,573
price ÷ annual EPS
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Visit websiteAs of August 10, 2026, Apnimed, Inc. (APMD) is worth $1.08B — this is its market capitalization, the total value of all its outstanding shares.
Apnimed, Inc.’s market cap is $1.08B, which ranks it #2534 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Apnimed, Inc. (APMD) shares trade at $27.00, down 3.16% on the day, as of August 10, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.